Role of genetics in inflammatory cardiomyopathy
- 11 January 2024
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 400, 131777
Abstract
No abstract availableKeywords
Funding Information
- Ministero della Salute (GR-2019-12368506)
- AstraZeneca
- Cytokinetics
- European Commission (PNRR-MAD-2022-12376225)
This publication has 109 references indexed in Scilit:
- Evaluation of the Role of Endomyocardial Biopsy in 851 Patients With Unexplained Heart Failure From 2000–2009Circulation: Heart Failure, 2013
- Diagnosis, Treatment, and Outcome of Giant-Cell Myocarditis in the Era of Combined ImmunosuppressionCirculation: Heart Failure, 2013
- Arrhythmogenic right ventricular cardiomyopathy: severe structural alterations are associated with inflammationJournal of Clinical Pathology, 2012
- Altered Desmosomal Proteins in Granulomatous Myocarditis and Potential Pathogenic Links to Arrhythmogenic Right Ventricular CardiomyopathyCirculation: Arrhythmia and Electrophysiology, 2011
- Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionalsGenetics in Medicine, 2010
- Cardiovascular Magnetic Resonance in Myocarditis: A JACC White PaperJACC, 2009
- Isolated Cardiac Sarcoidosis Associated with the Expression of a Splice Variant Coding for a Truncated BTNL2 ProteinCardiology, 2007
- Evaluation of Postmortem Endomyocardial Biopsy Specimens From 38 Patients With Lymphocytic Myocarditis: Implications for Role of Sampling ErrorMayo Clinic Proceedings, 1989
- Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditisJACC, 1989
- Right Ventricular Cardiomyopathy and Sudden Death in Young PeopleNew England Journal of Medicine, 1988